Citation: S. Derby et al., SYSTEMIC OPIOID THERAPY FOR CHRONIC CANCER PAIN - PRACTICAL GUIDELINES FOR CONVERTING DRUGS AND ROUTES OF ADMINISTRATION, CNS DRUGS, 9(2), 1998, pp. 99-109
Authors:
CHRISTIE JM
SIMMONDS M
PATT R
COLUZZI P
BUSCH MA
NORDBROCK E
PORTENOY RK
Citation: Jm. Christie et al., DOSE-TITRATION, MULTICENTER STUDY OF ORAL TRANSMUCOSAL FENTANYL CITRATE FOR THE TREATMENT OF BREAKTHROUGH PAIN IN CANCER-PATIENTS USING TRANSDERMAL FENTANYL FOR PERSISTENT PAIN, Journal of clinical oncology, 16(10), 1998, pp. 3238-3245
Citation: Dk. Payne et Rk. Portenoy, PAIN-RELATED COGNITIONS ASSOCIATED WITH INCREASED PAIN INTENSITY, PSYCHOLOGICAL DISTRESS AND FUNCTIONAL INTERFERENCE IN CANCER PAIN PATIENTS, Psychosomatic medicine, 60(1), 1998, pp. 121-121
Authors:
BURRIS HA
MOORE MJ
ANDERSEN J
GREEN MR
ROTHENBERG ML
MADIANO MR
CRIPPS MC
PORTENOY RK
STORNIOLO AM
TARASSOFF P
NELSON R
DORR FA
STEPHENS CD
VANHOFF DD
Citation: Ha. Burris et al., IMPROVEMENTS IN SURVIVAL AND CLINICAL BENEFIT WITH GEMCITABINE AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED PANCREAS CANCER - A RANDOMIZED TRIAL, Journal of clinical oncology, 15(6), 1997, pp. 2403-2413
Authors:
CARACENI A
MARTINI C
ZECCA E
DECONNO F
PORTENOY RK
Citation: A. Caraceni et al., PAIN DUE TO EPIDURAL TUMOR IN CANCER-PATIENTS - REPORT OF 2 CASES ANDDIFFERENTIAL-DIAGNOSIS, Italian journal of neurological sciences, 18(5), 1997, pp. 303-307
Authors:
PORTENOY RK
DOLE V
JOSEPH H
LOWINSON J
RICE C
SEGAL S
RICHMAN BL
Citation: Rk. Portenoy et al., PAIN MANAGEMENT AND CHEMICAL DEPENDENCY - EVOLVING PERSPECTIVES, JAMA, the journal of the American Medical Association, 278(7), 1997, pp. 592-593
Authors:
VOGELZANG NJ
BREITBART W
CELLA D
CURT GA
GROOPMAN JE
HORNING SJ
ITRI LM
JOHNSON DH
SCHERR SL
PORTENOY RK
Citation: Nj. Vogelzang et al., PATIENT, CAREGIVER, AND ONCOLOGIST PERCEPTIONS OF CANCER-RELATED FATIGUE - RESULTS OF A TRIPART ASSESSMENT SURVEY, Seminars in hematology, 34(3), 1997, pp. 4-12
Authors:
PORTENOY RK
COYLE N
KASH KM
BRESCIA F
SCANLON C
OHARE D
MISBIN RI
HOLLAND J
FOLEY KM
Citation: Rk. Portenoy et al., DETERMINANTS OF THE WILLINGNESS TO ENDORSE ASSISTED SUICIDE - SURVEY OF PHYSICIANS, NURSES, AND SOCIAL-WORKERS, Psychosomatics, 38(3), 1997, pp. 277-287
Citation: Rk. Portenoy, OPIOID THERAPY FOR CHRONIC NONMALIGNANT PAIN - CLINICIAN PERSPECTIVE, The Journal of law, medicine & ethics, 24(4), 1996, pp. 296-309
Authors:
ROTHENBERG ML
MOORE MJ
CRIPPS MC
ANDERSEN JS
PORTENOY RK
BURRIS HA
GREEN MR
TARASSOFF PG
BROWN TD
CASPER ES
STORNIOLO AM
VONHOFF DD
ALBERTS DS
WOLFF R
KELSEN DP
KOCHA W
HALLER DG
MODIANOREVAH M
MOORE M
OKEN MM
SCHILSKY RL
SHAH A
Citation: Ml. Rothenberg et al., A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER, Annals of oncology, 7(4), 1996, pp. 347-353
Authors:
BOOKBINDER M
COYLE N
KISS M
GOLDSTEIN ML
HOLRITZ K
THALER H
GIANELLA A
DERBY S
BROWN M
RACOLIN A
HO MN
PORTENOY RK
Citation: M. Bookbinder et al., IMPLEMENTING NATIONAL STANDARDS FOR CANCER PAIN MANAGEMENT - PROGRAM MODEL AND EVALUATION, Journal of pain and symptom management, 12(6), 1996, pp. 334-347
Citation: Rk. Portenoy, REPORT FROM THE INTERNATIONAL-ASSOCIATION-FOR-THE-STUDY-OF-PAIN TASK-FORCE ON CANCER PAIN, Journal of pain and symptom management, 12(2), 1996, pp. 93-96
Citation: Rk. Portenoy, OPIOID THERAPY FOR CHRONIC NONMALIGNANT PAIN - A REVIEW OF THE CRITICAL ISSUES, Journal of pain and symptom management, 11(4), 1996, pp. 203-217
Citation: Rk. Portenoy, MORPHINE INFUSIONS AT THE END OF LIFE - THE PITFALLS IN REASONING FROM ANECDOTE, Journal of palliative care, 12(4), 1996, pp. 44-46